Presentation TCT 2024 Conduction Abnormalities after TTVI – Clinical Implications and Therapeutic Options Presenter: Andrea Scotti October 29, 2024
Presentation TCT 2024 TCT 698: Prevalence and Prognostic Impact of Clinical and Anatomical Characteristics Suggesting Complex Pad in Patients Undergoing Surgical vs Endovascular Revascularization Presenter: Serdar Farhan October 29, 2024
Presentation TCT 2024 TCT 15: Impact of High Lipoprotein(a) Levels on 5-Year Clinical Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stent in Korean Population Presenter: Woo Jin Ahn October 29, 2024
Presentation TCT 2024 TCT 283: Clinical Outcomes of Patients Receiving IABP From the Cardiogenic Shock Working Group: A Comparison of Heart Failure and Myocardial Infarction Related Cardiogenic Shock Presenter: Arthur Garan October 29, 2024
Presentation TCT 2024 TCT 570: Women Clinical Outcomes of Percutaneous Coronary Intervention in Left Main Coronary Artery Disease at 17-Year Long-Term Follow-Up Presenter: Ignacio Sanchez-Perez October 29, 2024
Presentation TCT 2024 The Trisol TTVR System: Technology Differentiation and Early Clinical Experience Presenter: Isaac George October 29, 2024
Presentation TCT 2024 Case 3: TR with Large Gaps and a Large Annulus Presenter: Rishi Puri October 29, 2024
Presentation TCT 2024 The LuX-Valve Plus Transjugular TTVR System: One-Year Outcomes of a Multicenter Clinical Study in High Surgical Risk TR Patients Presenter: Juan Granada October 29, 2024
Presentation TCT 2024 What Next After Establishing the Diagnosis: Risk Stratification for Acute PE Presenter: Amir Darki October 29, 2024
Presentation TCT 2024 Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial Presenter: Samir Kapadia October 29, 2024
Presentation TCT 2024 Health Equity in the Care of the Pulmonary Embolism Patient Presenter: Peter Monteleone October 29, 2024
Presentation TCT 2024 The Cardiovalve TTVR Clinical Program Presenter: Christian Frerker October 29, 2024
Presentation TCT 2024 Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials Presenter: Didier Tchetche October 29, 2024
Presentation TCT 2024 PE in 2024: Why Should Cardiologist Care? Presenter: Sripal Bangalore October 29, 2024
Presentation TCT 2024 Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation: The ACCESS-TAVI Randomized Trial Presenter: Tobias Rheude October 29, 2024
Presentation TCT 2024 Case 2: Device Choice for TR When RV Leads Are Present Presenter: Christian Besler October 29, 2024
Presentation TCT 2024 Colchicine in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Double-Blind Randomized Controlled Trial Presenter: Thomas Pilgrim October 29, 2024
Presentation TCT 2024 Case 1: Atrial Functional TR - Preferred Device Choices Presenter: Mirjam Wild October 29, 2024
Presentation TCT 2024 The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation Presenter: Torsten Vahl October 29, 2024